BR9805088A - Derivados de benzopirano substituìdos por sulfonamida , processo para sua preparação, seu uso como mdo os mesmos. - Google Patents

Derivados de benzopirano substituìdos por sulfonamida , processo para sua preparação, seu uso como mdo os mesmos.

Info

Publication number
BR9805088A
BR9805088A BR9805088A BR9805088A BR9805088A BR 9805088 A BR9805088 A BR 9805088A BR 9805088 A BR9805088 A BR 9805088A BR 9805088 A BR9805088 A BR 9805088A BR 9805088 A BR9805088 A BR 9805088A
Authority
BR
Brazil
Prior art keywords
sulfonamide
preparation
derivatives substituted
benzopyran derivatives
treatment
Prior art date
Application number
BR9805088A
Other languages
English (en)
Inventor
Joachim Dr Brendel
Uwe Dr Gerlach
Hans Jochen Dr Lang
Klaus Dr Weidmann
Original Assignee
Hoechst Marion Roussel De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel De Gmbh
Publication of BR9805088A publication Critical patent/BR9805088A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

UBSTITUìDOS POR SULFONAMIDA, PROCESSO PARA SUA PREtos da fórmula I que apresentam os significados dos substituintes indicados nas reivindicações são destacadamente substâncias ativas para a produção de medicamentos para a profilaxia e para a terapia itmias, para o tratamento de úlceras de região gastrintestinal ou para o tratamento de doenças ligadas à diarréia.
BR9805088A 1997-11-03 1998-11-03 Derivados de benzopirano substituìdos por sulfonamida , processo para sua preparação, seu uso como mdo os mesmos. BR9805088A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19748469A DE19748469A1 (de) 1997-11-03 1997-11-03 Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
BR9805088A true BR9805088A (pt) 2000-03-21

Family

ID=7847428

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9805088A BR9805088A (pt) 1997-11-03 1998-11-03 Derivados de benzopirano substituìdos por sulfonamida , processo para sua preparação, seu uso como mdo os mesmos.

Country Status (29)

Country Link
US (1) US6008245A (pt)
EP (1) EP0913396B1 (pt)
JP (1) JP4430749B2 (pt)
KR (1) KR19990044961A (pt)
CN (1) CN1218050A (pt)
AR (1) AR015997A1 (pt)
AT (1) ATE250051T1 (pt)
AU (1) AU740814B2 (pt)
BR (1) BR9805088A (pt)
CA (1) CA2252733A1 (pt)
CZ (1) CZ293913B6 (pt)
DE (2) DE19748469A1 (pt)
DK (1) DK0913396T3 (pt)
ES (1) ES2203867T3 (pt)
HR (1) HRP980576B1 (pt)
HU (1) HUP9802518A3 (pt)
ID (1) ID21209A (pt)
IL (1) IL126855A (pt)
MY (1) MY118262A (pt)
NO (1) NO985023L (pt)
NZ (1) NZ332575A (pt)
PL (1) PL329437A1 (pt)
PT (1) PT913396E (pt)
RU (1) RU2225403C2 (pt)
SI (1) SI0913396T1 (pt)
SK (1) SK284859B6 (pt)
TR (1) TR199802200A2 (pt)
TW (1) TW593307B (pt)
ZA (1) ZA989982B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5408940A (en) * 1992-06-25 1995-04-25 Winchell; Paul W. Adjustable height work surface wtih rack and pinion arrangements
DE19858253A1 (de) * 1998-12-17 2000-06-21 Aventis Pharma Gmbh Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden
KR100512486B1 (ko) * 2003-05-28 2005-09-06 동부한농화학 주식회사 싸이옥소벤즈옥사졸 유도체로 치환된 벤조피란 유도체또는 약학적으로 허용되는 염, 이의 제조방법 및 이를포함하는 약학적 조성물
KR100545780B1 (ko) * 2003-05-28 2006-01-24 동부한농화학 주식회사 벤즈이미다졸 유도체로 치환된 벤조피란 유도체 또는약학적으로 허용되는 그의 염, 이의 제조 방법 및 이를포함하는 약학적 조성물
JP4971304B2 (ja) * 2005-04-12 2012-07-11 ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング アミノアルキル−アミドメチル置換２−スルホニルアミノ）−３−ヒドロキシ−３，４−ジヒドロ−２ｈ−クロメン−６−イル誘導体およびそのカリウムチャンネル遮断薬としての使用
WO2012012473A1 (en) 2010-07-19 2012-01-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of delta tocopherol for the treatment of lysosomal storage disorders
JP6367211B2 (ja) 2012-11-16 2018-08-01 ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ リソソーム蓄積症の改善物質としてのトコフェロール誘導体およびトコフェリルキノン誘導体
US9573921B2 (en) * 2013-09-30 2017-02-21 Polfarmex S.A. Substituted N, N-dimethylaminoalkyl ethers of isoflavanone oximes as H1-receptor antagonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3737195A1 (de) * 1987-11-03 1989-05-18 Bayer Ag Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
GB8808069D0 (en) * 1988-04-07 1988-05-11 Fujisawa Pharmaceutical Co Benzopyran derivatives & processes for preparation thereof
US5104890A (en) * 1989-03-28 1992-04-14 Fujisawa Pharmaceutical Company, Ltd. Benzopyran derivatives and processes for preparation thereof
HRP970255B1 (en) * 1996-05-15 2003-10-31 Hoechst Ag Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents as well as medicaments containing them
DE19706675A1 (de) * 1997-02-20 1998-08-27 Hoechst Ag Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19742508A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DE19742509A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
EP0913396A2 (de) 1999-05-06
HRP980576A2 (en) 1999-06-30
HUP9802518A3 (en) 2001-10-29
TR199802200A3 (tr) 1999-05-21
PL329437A1 (en) 1999-05-10
JP4430749B2 (ja) 2010-03-10
TW593307B (en) 2004-06-21
NO985023D0 (no) 1998-10-28
SI0913396T1 (en) 2004-02-29
US6008245A (en) 1999-12-28
DE19748469A1 (de) 1999-05-06
RU2225403C2 (ru) 2004-03-10
IL126855A (en) 2003-03-12
HU9802518D0 (en) 1998-12-28
JPH11222485A (ja) 1999-08-17
DE59809628D1 (de) 2003-10-23
EP0913396B1 (de) 2003-09-17
AU9043798A (en) 1999-05-20
HUP9802518A2 (hu) 2000-06-28
HRP980576B1 (en) 2002-10-31
CZ293913B6 (cs) 2004-08-18
CN1218050A (zh) 1999-06-02
CZ350898A3 (cs) 1999-05-12
KR19990044961A (ko) 1999-06-25
IL126855A0 (en) 1999-09-22
ZA989982B (en) 1999-06-24
ATE250051T1 (de) 2003-10-15
EP0913396A3 (de) 2001-03-21
MY118262A (en) 2004-09-30
PT913396E (pt) 2004-02-27
DK0913396T3 (da) 2003-12-22
TR199802200A2 (xx) 1999-05-21
CA2252733A1 (en) 1999-05-03
AU740814B2 (en) 2001-11-15
SK284859B6 (sk) 2006-01-05
NZ332575A (en) 2000-03-27
AR015997A1 (es) 2001-05-30
ES2203867T3 (es) 2004-04-16
NO985023L (no) 1999-05-04
SK149498A3 (en) 1999-05-07
ID21209A (id) 1999-05-06

Similar Documents

Publication Publication Date Title
BR0017030B8 (pt) derivados de tiazolilamida, processo para sua preparação, composição farmacêutica que os compreende e uso dos mesmos
BRPI0516842A (pt) compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento terapêutico e/ou profilático de enfermidades que são moduladas por lxr alfa e/ou lxr beta agonistas e uso desses compostos
BR0307294A (pt) ésteres de ácido fluorenocarboxìlico, processo para sua preparação bem como seu uso como medicamento
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
ES2075011T3 (es) Uso de sales del acido gamma-hidroxibutirico para preparar composiciones farmaceuticas para uso en el tratamiento del alcoholismo, y las composiciones obtenidas.
MX9203653A (es) Composiciones amfotericas y formas polimericas de los alfa-hidroxiacidos.
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
ATE232393T1 (de) Verwendung von substanzen mit oxytocinwirkung zur herstellung von arzneimitteln zur wundheilung
ATE40555T1 (de) Verfahren zur organischen synthese von oligosacchariden,welche galactosamin- und uronsaeure-motive umfassen, oligosaccharide und ihre biologischen verwendungen.
BR0011831A (pt) Compostos, processo para preparar os mesmos, composições farmacêuticas, e, uso dos compostos
BR0313043A (pt) Conjugados efetores, processo para sua produção e seu uso farmacêutico
EP0360077A3 (de) Verwendung von Serotonin-Antagonisten bei der Behandlung von Apoplexia cerebri
ES2192680T3 (es) Nuevos derivados de vitamina d con sustituyentes carbo- o heterociclicos en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
BR0307461A (pt) Derivados de quinazolinona e seu uso como agonistas de cb
BR9805088A (pt) Derivados de benzopirano substituìdos por sulfonamida , processo para sua preparação, seu uso como mdo os mesmos.
FI885377A0 (fi) Foerfarande foer framstaellning av nya metronidazolsammansaettningar foer lokal administration.
EA200200096A1 (ru) Новые производные витамина d с циклическими субструктурами в боковых цепях, способ и промежуточные продукты для их получения и их применение для получения лекарственных средств
ATE69953T1 (de) Verwendung von polysulfatierten heparinen.
BR0008682A (pt) 3-amino-3-arilpropan-1-ol, processo para sua produção, seu uso e medicamento
BR0115045A (pt) Compostos, processo para sua preparação, composição farmacêutica que compreende os mesmos, sua utilização, processo para o tratamento e profilaxia de artrite, diabetes, distúrbios alimentares e obesidade
ES2092868T3 (es) Utilizacion de derivados de la 4-tiorresorcina en unas composiciones cosmeticas o dermofarmaceuticas de accion despigmentante.
YU13699A (sh) Primena 1-hidroksi-2-piridona za dobijanje leka za lečenje infekcija kože
MX9302487A (es) Piridonas sustituidas por bifenilmetilo, procedimiento para su obtencion y medicamentos que las contienen.
ES2058343T3 (es) Piridinas disubstituidas.
BR9803367A (pt) Cromanos substituìdos por sulfonamida, processos para a sua preparação, seu emprego como medicamento e preparados farmacêuticos contendo os mesmos

Legal Events

Date Code Title Description
TC Change of name
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements